Abstract
Up to 80% of all transitional cell carcinomas of the urinary bladder are found to be superficial at the time of diagnosis (Ta-T1). In spite of a 50% recurrence rate and a 10%–15% progression rate, these tumors can be controlled adequately by transurethral resection (TURB) and intravesical chemotherapy or immunotherapy. However, poorly differentiated T1 tumors and muscle-invasive tumors (>T2) require a more aggressive treatment approach.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abradt RP, Pontin AR, Barnes RD (1993) Chemotherapy versus radical irradiation plus salvage-cystectomy for bladder cancer severe late small bowel morbidity. Eur J Surg Oncol 19: 279–282
Birkenhake S, Sauer R, Kühn R, Martus P, Wittekind C, Schrott KM (1997) Effekte der simultan zur Radiotherapie applizierten Chemotherapie bei der Primärtherapie des muskelinvasiven Blasenkarzinoms. Strahlenther Onkol 173;••-••
Blandy JP, England HR, Evans SJW, Hope-Stone HF, Mair GM, Mantell BS, Oliver RT (1980) T3 bladder cancer–the case for salvage cystectomy. Br J Urol 52: 506–510
Bloom HJG, Hendry WF, Wallace DM, Skeot RG (1982) Treatment of T3 bladder cancer: controlled trial of pre-operation radiotherapy and radical cystectomy versus radical radiotherapy. Br J Urol 54: 136–151
Cervak J, Cufer T, Kragelj B, Zakotnik B, Stanonik M (1993) Sequential transurethral surgery, multiple drug chemotherapy and radiation therapy for invasive bladder carcinoma: initial report. Int J Radiat Biol Phys 25: 777–782
Chauvet B, Brewer J, Felix-Faire C, Davin JL, Viecet P, Rebrul F (1993) Combined radiation therapy and cisplatin for locally advanced carcinoma of the urinary bladder. Cancer 72: 2213–2218
Coppin C, Cospordarowicz M, Dixon P (1992) Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or radical radiation. Proc Am Soc Clin Oncol 11: 198–201
De Neve W, Lybeert ML, Goor C, Crommelin MA, Ribot JG (1995) Radiotherapy for T2 and T3 carcinoma of the bladder: the influence of overall treatment time. Radiother Oncol 36: 183–188
Duncan W, Quilty W (1986) The result of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-tray therapy. Radiother Oncol 7: 299–310
Dunst J, Sauer R, Schrott KM, Kühn R, Wittekind C, Altendorf-Hofmann A (1994) Organ sparing treatment of advanced bladder cancer. A 10 year experience. Int J Radiat Oncol Biol Phys 30: 261–266
Dunst J (1991) Die Radiotherapie im interdisziplinären Behandlungskonzept des Harnblasenkarzinoms. Strahlenther Onkol 167: 563–580
Fung CY, Shipley WU, Young RH, et al. (1991) Prognostic factors in invasive bladder carcinoma in a prospective trial of preoperative adjuvant chemotherapy and radiotherapy. J Clin Oncol 9: 1533–1542
Goodman GD, Hilop TG, Elvord JM, Balfour J (1981) Conservation of bladder function in patients with invasive bladder cancer treated by definitive irriadiative and selective cystectomy. Int J Radiol Oncol Biol Phys 7: 569–573
Gospodarowicz MK, Hawkins MV, Rawlings GA, et al. (1989) Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: failure analysis. J Urol 142: 1448–1454
Housset M, Maulard C, Chretien Y, et al. (1993) Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study. J Clin Oncol 11: 2150–2157
Jahnson S, Petersen J, Westman G (1991) Bladder carcinoma–a 20 year review of radical irradiation therapy. Radiother Oncol 22: 111–117
Jakse G, Frommhold N, Nedden D (1985) Combined radiation and chemotherapy for locally advanced transitional cell carcinoma of the urinary bladder. Cancer 55: 1659–1664
Jenkins BJ, Caulfield MJ, Fowler CG, et al. (1988) Reappraisal of the role of radical radiotherapy and salvage cystectomy in the treatment of invasive (T2/T3) bladder cancer. Br J Urol 62: 343–346
Jung P, Jakse G (1996) Bladder preservation in invasive locally confined bladder cancer. Onkologie 19: 296–301
Kachnic LA, Kaufman DS, Zietman AI, et al. (1995) Selective bladder preservation by combined modality therapy for invasive bladder cancer. Int J Radiat Oncol Biol Phys 32 (Suppl): 271
Kaufman DS, Shipley WU, Griffin PP, Heney NM, Althanter AF, Eford JG (1993) Selective bladder preservation by combination treatment of invasive bladder cancer. N Engl J Med 329: 1377–1381
Koiso K, Shipley W, Keuppens F, et al. (1995) The status of bladder-preserving therapeutic strategies in the management of patients with muscle-invasive bladder cancer. Int J Urol (Jpn) 2 (Suppl 2): 49–57
Mameghan H, Fisher R, Mameghan J, Brook S (1995) Analysis of failure following definitive radiotherapy for invasive transitional cell carcinoma of the bladder. Int J Radiat Oncol Biol Phys 31: 247–254
Martinez-Pineiro JA, Gonzalez M, Arocena F, Flores N, Roncero CR, Portillo JA, Escudero A (1995) Neoadjuvant cisplatin chemotherapy before radical cystectomy in invasive transitional cell carcinoma of the bladder: a prospective randomized phase III study. J Urol 153: 964–973
Miller LS, Johnson DE (1973) Megavoltage irradiation for bladder cancer. Cancer 10: 771–782
Pagano F, Bassi P, Galetti TP (1991) Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with emphasis on the inadequacy of the tumor, nodes and metastases classification. J Urol 145: 45–49
Quilty PM, Duncan W (1985) Primary radical radiotherapy for T3 transitional cell cancer of the bladder: an analysis of survival and control. Int J Radiat Oncol Biol Phys 12: 853–860
Rebischung JC, Vannetzel JM, Fournier F (1992) Cyclic concomitant chemoradiotherapy for invasive bladder cancer: phase 2 study with organ preservation. Proc Am Soc Clin Oncol 11: 208–214
Rhagavan D, Shipley WU, Garnick MB, Russel PM, Richie JP (1990) Biology and management of bladder cancer. N Engl J Med 322: 1129–1138
Rotman M, Macchia R, Silverstein R (1987) Treatment of advanced bladder cancer with irradiation and concomitant 5fluorouracil infusion. Cancer 59: 710–715
Russel KJ, Boileau MA, Higano C, et al. (1990) Combined 5fluorouracil and irradiation for transitional cell carcinoma of the urinary bladder. Int J Radiat Oncol Biol Phys 19: 693–699
Sauer R, Dunst J, Altendorf-Hofmann A, Fischer H, Bornhof C, Schrott KM (1990) Radiotherapy with and without cisplatin in bladder cancer. Int J Radiat Oncol Biol Phys 19: 687–691
Sauer R, Birkenhake S, Martus P (1996) Efficacy of radiochemo-therapy with platin-derivatives compared to radiotherapy alone in organ sparing treatment of bladder cancer. Int J Radiat Oncol Biol Phys 36 (Suppl): 142
Scher H, Herr H, Sternberg C, et al. (1989) Neo-adjuvant chemotherapy for invasive bladder cancer. Experience with the M-VAC regimen. Br J Urol 64: 250–256
Sell A, Jakobsen A, Nerstrom B, Sorensen BL, Steven K, Barlebo H (1991) Treatment of advanced bladder cancer category T2, T3 and T4a. A randomized multicenter study of preoperative irradiation and cystectomy versus radical irradiation and early salvage cystectomy for residual tumor. DAVECA protocol 8201. Danish Vesical Cancer Group. Scand J Urol Nephrol (Suppl) 138: 193–201
Shearer RJ, Chilvers CE, Bloom HJ, Horwich A, Batiker H (1988) Adjuvant chemotherapy in T3 carcinoma of the bladder. Br J Urol 62: 558–564
Shipley WU, Prout GR, Einstein AB, et al. (1987) Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery. JAMA 258: 931–935
Skinner DG, Lieskovsky G (1988) Management of invasive and high grade bladder cancer. In: Diagnosis and management of genitourinary cancer. Saunders, Philadelphia, p 295
Smaaland R, Aksilen LA, Tonder B, et al. (1991) Radical radiation therapy of invasive and locally advanced bladder carcinoma in elderly patients. Br J Urol 67: 61–69
Stöckle M, Riedmüller H, Hohenfellner R (1991) Radikale Zystektomie–oft zu spät? Therapieergebnisse der radikalen Zystektomie mit and ohne adjuvante oder induktive M-VAC Behandlung. In: Hartung R, Hübner W, Kropp W (ed) Urologische Beckenchirurgie. Springer, Berlin Heidelberg New York, pp 279–287
Tester W, Porter A, Asbell S, et al. (1993) Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85–12. Int J Radiat Oncol Biol Phys 25: 783–790
Whitmore WF, Batata MA, Thoneim MA, Grabstald H, Unal A (1988) Radical cystectomy with or without prior irradiation in the treatment of bladder cancer. J Urol 139: 299A
Wishnow KI, Levinson AK, Johnson DE (1992) Stage B (T2/ 3aNO) transitional cell carcinoma of the bladder highly curable by radical cystectomy. Urology 39: 1–9
Zietman AL, Shipley WU, Kaufman DS (1993) The combination of cisplatin based chemotherapy and radiation with treatment of muscle invading transitional cell cancer of the bladder. Int J Radiat Oncol Biol Phys 27: 161–170
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Sauer, R. et al. (1998). Muscle-Invasive Bladder Cancer: Transurethral Resection and Radiochemotherapy as an Organ-Sparing Treatment Option. In: Petrovich, Z., Baert, L., Brady, L.W. (eds) Carcinoma of the Bladder. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60258-0_18
Download citation
DOI: https://doi.org/10.1007/978-3-642-60258-0_18
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64323-1
Online ISBN: 978-3-642-60258-0
eBook Packages: Springer Book Archive